Analysis of Three Declining Growth Stocks
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 22 2026
0mins
Should l Buy FIG?
Source: Fool
- Figma Price Decline: Figma's stock has fallen 72% from its 2025 peak, currently trading at $26.23, and despite a 40% revenue growth in Q4, market expectations for future growth remain low, leading to diminished investor confidence.
- CoreWeave's Performance Fluctuations: CoreWeave's stock has dropped from a summer high of $187 to $89.15, and while its revenue has more than tripled over the past year with analysts expecting it to double in 2026, the market remains cautious about its short-term performance.
- Recursion's Poor Stock Performance: Recursion Pharmaceuticals' stock has lost 66% of its value over the past year, currently priced at $3.42, and although its partnership with Nvidia initially drew market attention, Nvidia's complete exit from its stake has failed to boost the stock price.
- Investor Sentiment Deterioration: Despite Cathie Wood's continued investment in these three stocks, overall market confidence in growth stocks has weakened, particularly amid intensified competition in the AI sector and a sell-off in SaaS stocks, prompting investors to carefully assess risks and opportunities.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy FIG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on FIG
Wall Street analysts forecast FIG stock price to rise
9 Analyst Rating
3 Buy
6 Hold
0 Sell
Moderate Buy
Current: 29.290
Low
38.00
Averages
53.13
High
70.00
Current: 29.290
Low
38.00
Averages
53.13
High
70.00
About FIG
Figma, Inc. designs and develops platforms for people who build digital products together. The Company helps cross-functional teams align and build software more efficiently and ensure the advanced access and controls that large organizations require. Its products include Figma Design, Dev Mode, Figma Sites, Figma Make, Figma Draw, Figma Buzz, FigJam and Figma Slides. Figma Sites is a product that lets clients design a Website and directly publish it to the Web, with a custom URL. Figma Make is an AI-powered tool that turns a prompt into a fully functional prototype. Figma Buzz is a product for easily creating marketing assets (like social media assets and digital ads) at a scale that is consistent with brand or visual identity. Figma Draw provides a space for finer vector editing required when drawing detailed iconography and product illustrations. Figma Design combines powerful features with a collaborative workspace to help teams design and build better products together.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Stock Recovery: Figma's stock rose 13% in February, although it remains down 77% since its IPO, indicating a gradual restoration of market confidence in its growth prospects.
- Strong User Growth: Weekly active users are growing at an astonishing 70% quarter-over-quarter, reflecting rapid adoption of Figma's products in the enterprise market, which has driven a 40% year-over-year revenue increase to $303 million.
- Market Position Strengthened: By simplifying real-time collaboration in digital design, Figma has successfully disrupted Adobe's dominance in the sector, attracting nearly 14,000 customers paying over $10,000 annually, demonstrating broad acceptance in the enterprise market.
- Cautious Future Outlook: Despite Figma's guidance for $1.37 billion in revenue this fiscal year, resulting in a forward price-to-sales ratio of 11, it is still considered relatively expensive, with expected operating earnings just over $100 million and a pre-tax earnings multiple of 150, suggesting limited future stock market returns.
See More
- Stock Volatility: Figma's stock has plummeted approximately 80% from its 52-week high of $142.92, currently trading at $29.38 with a market cap of $15 billion, reflecting market concerns about its long-term growth potential.
- Collaborative Opportunity: The partnership with AI chatbot Claude introduces the 'Code to Canvas' feature, enabling users to easily convert code into modifiable designs, aimed at enhancing user experience and strengthening its competitive edge in the design sector.
- Financial Performance: Figma's recent quarterly report revealed revenue of $303.8 million for the last three months of 2025, marking a 40% year-over-year growth, indicating robust growth potential despite the looming AI threat.
- Market Confidence: Despite bearish sentiment towards software companies, Figma's stock has risen 22% over the past month, as investors express optimism regarding its collaboration with Anthropic and a projected 38% revenue growth for the current quarter.
See More
- Disruption Indicators: In a recent podcast, analysts discussed historical disruption cases, highlighting that persistently declining gross margins and customer attrition are key signs of companies facing disruption, which is crucial for investor decision-making.
- Salesforce's Challenges: Salesforce is projected to generate approximately $41 billion in revenue for 2026, yet its annualized AI agent business is only $1.4 billion, and sluggish growth places it at risk of disruption, especially in an increasingly competitive market.
- Market Reaction: While the S&P 500 and NASDAQ saw slight gains last week, the software-as-a-service (SaaS) sector experienced sharp sell-offs, intensifying investor concerns about potential disruptions and reflecting market uncertainty about the industry's future.
- Investor Mindset: Analysts emphasized the importance of maintaining courage amid fear, asserting that investors must possess the ability to act against market trends to navigate volatility and seize potential investment opportunities.
See More
- Figma Investment Update: Ark Innovation ETF purchased additional shares of Figma on February 23, making it the 38th largest holding at 0.66% of the total portfolio; despite concerns about slowing growth, Figma's 40% year-over-year sales increase in Q4 indicates strong market potential.
- CRISPR Holdings Overview: On February 20, Ark increased its stake in CRISPR Therapeutics, now the second-largest holding at 6.64% of the fund, with only $3.5 million in sales last year, yet the potential commercialization of gene-editing drugs could lead to explosive growth, representing a high-risk, high-reward investment.
- CoreWeave Investment Outlook: Ark also bought more shares of CoreWeave on February 20, making it the 18th largest holding at approximately 2% of the ETF; the company is benefiting from surging AI processing demand and is expected to see significant sales growth with large orders on the horizon.
- Market Reaction Analysis: Although the performance of Ark Innovation ETF has been mixed, Cathie Wood's continued investment in these high-risk stocks reflects her strong confidence in the innovation sector, which may significantly impact the fund's overall performance in the coming years.
See More
- Investor Focus: Benzinga's Stock Whisper Index utilizes proprietary data and pattern recognition each week to highlight five undervalued stocks that deserve attention, aiding investors in uncovering new opportunities amidst information overload.
- Market Dynamics: Despite the multitude of methods available to retail traders, the challenge of sifting through abundant information to identify noteworthy stocks underscores the demand for information aggregation tools in the market.
- Data Source: Benzinga Pro serves as a vital channel for investors to access the latest market dynamics and headlines, reflecting the growing need for high-quality market analysis.
- Future Outlook: Investors should keep an eye on upcoming reports to stay attuned to market trends, as Benzinga's continuous updates will provide users with the latest market information and investment opportunities.
See More
- Oracle's AI Leadership: Oracle (ORCL) has gained attention over the past year as a leader in AI, with a backlog of $523 billion and $108 billion in debt, yet its stock price has dropped nearly 60% from its 52-week high, bringing its P/E ratio down to 28, slightly below the S&P 500 average of 30, highlighting its critical role in supporting AI infrastructure.
- Figma's Revenue Growth: Figma (FIG) achieved $1.06 billion in revenue for fiscal 2025, a 41% increase, despite a loss of $1.25 billion; however, its net dollar retention rate rose to 136%, indicating increased product popularity, and with its stock down over 80% from its IPO high, it presents a compelling entry point for investors.
- Zscaler's Growth Potential: Zscaler (ZS) reported a 26% revenue growth in Q1 of fiscal 2026, despite a 55% drop in stock price and intense competition, with its P/S ratio hitting an all-time low of 8, suggesting significant potential for new investors as it approaches profitability, allowing for the purchase of 6 shares at current prices.
- AI Impact and Market Response: While investors remain cautious about the future of AI-related stocks, the fundamentals of Oracle, Figma, and Zscaler indicate strong growth potential, particularly in AI and cloud computing, suggesting these stocks may deliver substantial returns in the future.
See More






